Business

Synthaverse Receives Marketing Authorization For Onko BCG Medicinal Product In Ecuador

Synthaverse Receives Marketing Authorization For Onko BCG Medicinal Product In Ecuador

Synthaverse Spolka AkcyjnaMay 27, 20265
Synthaverse Receives Marketing Authorization For Onko BCG Medicinal Product In Ecuador

About this update from Synthaverse Spolka Akcyjna

Synthaverse SA GPW:SVE:RECEIVES MARKETING AUTHORIZATION FOR ONKO BCG MEDICINAL PRODUCT IN ECUADOR

View stock analysis, news, and events for Synthaverse Spolka Akcyjna